<DOC>
	<DOC>NCT00818610</DOC>
	<brief_summary>The purpose of this study is to determine whether a monotherapy with a Beta-Lactam is not inferior to an association of a Beta-Lactam and a macrolide in treating adult patients with community-acquired pneumonia.</brief_summary>
	<brief_title>Monotherapy Versus Bitherapy in Non-severe Hospitalized Community-acquired Pneumonia</brief_title>
	<detailed_description />
	<mesh_term>Pneumonia</mesh_term>
	<mesh_term>Clarithromycin</mesh_term>
	<mesh_term>beta-Lactams</mesh_term>
	<mesh_term>Lactams</mesh_term>
	<mesh_term>Amoxicillin-Potassium Clavulanate Combination</mesh_term>
	<mesh_term>Amoxicillin</mesh_term>
	<mesh_term>Cefuroxime</mesh_term>
	<mesh_term>Cefuroxime axetil</mesh_term>
	<criteria>Age &gt;=18 years New infiltrate on chest Xray, unexplained by another disease process Presence of at least two of the following findings suggestive of pneumonia: fever or hypothermia, new or increasing cough, sputum production, pleuritic chest pain, tachypnea, dyspnea or focal signs on chest examination Need for hospitalization as defined by the emergency physician in charge of the patient Allergy to one of the study drugs Pregnancy Severe immunosuppression Recent (&lt;14 d) hospitalization, or currently hospitalized since &gt; 48 hours Residency in a nursing home Previous use of more than 24 hours of any antibiotic Severe communityacquired pneumonia</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>April 2013</verification_date>
	<keyword>Community-acquired infections</keyword>
	<keyword>Pneumonia</keyword>
	<keyword>Clinical Stability</keyword>
	<keyword>Antibiotics</keyword>
	<keyword>Combination therapy</keyword>
	<keyword>Atypical bacteria</keyword>
</DOC>